These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 7006888)

  • 41. [Therapy of psychosomatic pathology of the digestive tract with a combination of nortriptyline and fluphenazine].
    Sarti F; D'Imperio N; Milandri M; Soffritti M; Spongano P; Blotta A; Dal Monte PR
    Clin Ter; 1977 Mar; 80(6):537-44. PubMed ID: 862354
    [No Abstract]   [Full Text] [Related]  

  • 42. GI illness: treatment of the anxiety component.
    Chaplan A; Vanov SK
    Psychosomatics; 1977 Oct; 18(4):49-54. PubMed ID: 335424
    [No Abstract]   [Full Text] [Related]  

  • 43. Halazepam in anxious outpatients: a controlled study.
    Fann WE; Sullivan JL; Miller RD
    Curr Ther Res Clin Exp; 1974 Dec; 16(12):1281-6. PubMed ID: 4156291
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of functional disorders of the cardiovascular system with a new benzodiazepine preparation].
    Matteoli E; Lampugnani E; Zaini G; Riva D
    Minerva Med; 1974 Jun; 65(45):2481-4. PubMed ID: 4602654
    [No Abstract]   [Full Text] [Related]  

  • 45. [Role of grandaxin in the treatment of functional gastrointestinal diseases].
    Osipenko MF; Khramov IuA; Makarova TA; Vdovenko EG
    Ter Arkh; 2000; 72(10):23-7. PubMed ID: 11220871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of psychophysiologic indices for the prognosis of the clinical action of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI; Marshak OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):90-8. PubMed ID: 2907706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Value of Benzoctamine in digestive pathology].
    Chapuy H; Sambin P; Girard M
    Lyon Med; 1972 Feb; 227(4):365-7. PubMed ID: 5027784
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of functional cardiovascular and gastrointestinal disorders with NC-123].
    de Barros OM; Bourroul G
    Hospital (Rio J); 1968 Sep; 74(3):956-62. PubMed ID: 5303778
    [No Abstract]   [Full Text] [Related]  

  • 49. [The gefarnate-diazepam combination in the treatment of various gastrointestinal diseases].
    Vezzadini P; Giorgi-Conciato M; Tomassetti P; Finatti F
    Clin Ter; 1978 May; 85(3):274-9. PubMed ID: 679632
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of tranquilizers on the critical flicker fusion frequency in the visual analyzer].
    Ben'kovich BI; Marshak OV
    Fiziol Cheloveka; 1984; 10(6):999-1004. PubMed ID: 6151932
    [No Abstract]   [Full Text] [Related]  

  • 51. Double-blind study of a psychotropic-anticholinergic drug in gastric disorders.
    Cromwell HA
    Med Times; 1968 Sep; 96(9):933-8. PubMed ID: 4876840
    [No Abstract]   [Full Text] [Related]  

  • 52. [Gastronerton (metoclopramide) in gastrointestinal diseases. Clinical effect and tolerance].
    Conti F; Testaguzza F
    Fortschr Med; 1980 May; 98(19):753-6. PubMed ID: 7399389
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinico-pharmacologic analysis neurovegetotropic activity of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):743-50. PubMed ID: 6464592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Camazepam (Albego) in psychovegetative dysregulations and psychosomatic disorders].
    Petro W
    Ther Ggw; 1979 Mar; 118(3):362-74. PubMed ID: 34899
    [No Abstract]   [Full Text] [Related]  

  • 55. The treatment of functional and emotional symptoms in patients with gastrointestinal disorders.
    Fisher JW
    Curr Ther Res Clin Exp; 1969 May; 11(5):247-51. PubMed ID: 4977394
    [No Abstract]   [Full Text] [Related]  

  • 56. [Controlled therapeutic trial of gastroenteric diseases with psychogenic interference].
    Malaguti P
    Minerva Med; 1970 Feb; 61(11):479-84. PubMed ID: 5416957
    [No Abstract]   [Full Text] [Related]  

  • 57. [Changes in the antioxidative activity and phospholipid composition of the erythrocytes in neurosis patients as affected by fenazepam].
    Kaipova GD; Burlakova EB; Molochkina EM; Neznamov GG; Poiurovskiĭ MV
    Biull Eksp Biol Med; 1988 Feb; 105(2):171-3. PubMed ID: 3349146
    [No Abstract]   [Full Text] [Related]  

  • 58. [Controlled clinical study of a new combination of a tranquilizer and an anticholinergic drug in various gastrointestinal diseases].
    Maccà F; Caregaro L; Lauro S
    Minerva Dietol Gastroenterol; 1979; 25(1):33-40. PubMed ID: 36577
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of psychopharmacological agents for functional gastrointestinal disorders.
    Clouse RE; Lustman PJ
    Gut; 2005 Sep; 54(9):1332-41. PubMed ID: 16099800
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of G 33040 (Insidon) in disorders of the gastrointestinal system due to psychic factors].
    de Mattos H
    Hospital (Rio J); 1968 Aug; 74(2):403-8. PubMed ID: 5308666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.